Related stories
UniQure Says FDA Accepts Application for Huntington’s Gene Therapy
UniQure said the FDA accepted an application for its potential Huntington’s disease gene therapy.
L impact | REGULATION | Nov 02, 2026, 01:06 PM UTC
Catheter Precision Announces FDA 510(k) Clearance for VIVO System
The clearance enables use of the VIVO system in a broader patient population.
L impact | REGULATION | Nov 02, 2026, 01:05 PM UTC
Lupin Receives U.S. FDA Approval for Amifampridine Tablets
M impact | REGULATION | Nov 02, 2026, 12:34 PM UTC
FDA Places Partial Clinical Hold on Bright Minds’ IND for DEE
M impact | REGULATION | Nov 02, 2026, 12:32 PM UTC
FDA Grants Priority Review to uniQure Huntington’s Gene Therapy
The FDA granted priority review to uniQure’s Huntington’s disease gene therapy.
M impact | REGULATION | Nov 02, 2026, 12:23 PM UTC
Inovio Wins FDA Accelerated Approval for VOCERYQ
Inovio received FDA accelerated approval for VOCERYQ to reduce the frequency of surgery in adults with recurrent respiratory papillomatosis.
M impact | REGULATION | Nov 02, 2026, 12:23 PM UTC